277 related articles for article (PubMed ID: 29902281)
1. Circulating immune complexome analysis identified anti-tubulin-α-1c as an inflammation associated autoantibody with promising diagnostic value for Behcet's Disease.
Cheng Y; Zhao X; Chen Y; Li Y; Jia R; Zhu L; Huang C; Sun X; Deng H; Li Z
PLoS One; 2018; 13(6):e0199047. PubMed ID: 29902281
[TBL] [Abstract][Full Text] [Related]
2. Anti-tubulin-α-1C autoantibody in systemic lupus erythematosus: a novel indicator of disease activity and vasculitis manifestations.
Zhao X; Cheng Y; Gan Y; Jia R; Zhu L; Sun X
Clin Rheumatol; 2018 May; 37(5):1229-1237. PubMed ID: 29427009
[TBL] [Abstract][Full Text] [Related]
3. Anti-tubulin-alpha-1c antibody as a marker of value in Behçet syndrome.
Amin MM; Abdel Latif OM
Clin Rheumatol; 2022 Jun; 41(6):1759-1767. PubMed ID: 35128589
[TBL] [Abstract][Full Text] [Related]
4. Human anti-alpha-enolase antibody in sera from patients with Behçet's disease and rheumatologic disorders.
Lee JH; Cho SB; Bang D; Oh SH; Ahn KJ; Kim J; Park YB; Lee SK; Lee KH
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S63-6. PubMed ID: 19796536
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
[TBL] [Abstract][Full Text] [Related]
6. [Significance of anti-tubulin-α-1C autoantibody in systemic sclerosis].
Zhao J; Sun F; Li Y; Zhao XZ; Xu D; Li YN; Li YH; Sun XL
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1009-1013. PubMed ID: 33331306
[TBL] [Abstract][Full Text] [Related]
7. Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease.
Lee KH; Chung HS; Kim HS; Oh SH; Ha MK; Baik JH; Lee S; Bang D
Arthritis Rheum; 2003 Jul; 48(7):2025-35. PubMed ID: 12847697
[TBL] [Abstract][Full Text] [Related]
8. Identification of streptococcal proteins reacting with sera from Behçet's disease and rheumatic disorders.
Cho SB; Lee JH; Ahn KJ; Cho S; Park YB; Lee SK; Bang D; Lee KH
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S31-8. PubMed ID: 20868568
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic alterations associated with Behçet's disease.
Zheng W; Wu X; Goudarzi M; Shi J; Song W; Li C; Liu J; Chen H; Zhang X; Zeng X; Li HH
Arthritis Res Ther; 2018 Sep; 20(1):214. PubMed ID: 30249301
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase I and II autoantibodies in Behçet's disease.
Mentese A; Alver A; Demir S; Sumer A; Ozer Yaman S; Karkucak M; Aydin Capkin A; Us Altay D; Turan I
Acta Reumatol Port; 2017; 42(1):26-31. PubMed ID: 28198796
[TBL] [Abstract][Full Text] [Related]
11. Proteomic surveillance of autoimmunity in Behcet's disease with uveitis: selenium binding protein is a novel autoantigen in Behcet's disease.
Okunuki Y; Usui Y; Takeuchi M; Kezuka T; Hattori T; Masuko K; Nakamura H; Yudoh K; Usui M; Nishioka K; Kato T
Exp Eye Res; 2007 May; 84(5):823-31. PubMed ID: 17343851
[TBL] [Abstract][Full Text] [Related]
12. Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity.
Lee YJ; Kang SW; Song JK; Park JJ; Bae YD; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S41-5. PubMed ID: 17949550
[TBL] [Abstract][Full Text] [Related]
13. Serum anti-lysozyme is associated with disease activity of Behçet's disease.
Park JS; Kang MI; Ha YJ; Song JJ; Park YB; Lee SK; Lee SW
Int J Rheum Dis; 2017 Feb; 20(2):261-268. PubMed ID: 26890818
[TBL] [Abstract][Full Text] [Related]
14. Identification of Novel Biomarkers for Behcet Disease Diagnosis Using Human Proteome Microarray Approach.
Hu CJ; Pan JB; Song G; Wen XT; Wu ZY; Chen S; Mo WX; Zhang FC; Qian J; Zhu H; Li YZ
Mol Cell Proteomics; 2017 Feb; 16(2):147-156. PubMed ID: 27777341
[TBL] [Abstract][Full Text] [Related]
15. Identification of heat shock protein 27 as a novel autoantigen of Behçet's disease.
Chen P; Shi L; Jiang Y; Ji Y; Yan H; Sun S; Xun Y; Chen G; Wang X; Chen W; Du H
Biochem Biophys Res Commun; 2015 Jan; 456(4):866-71. PubMed ID: 25529454
[TBL] [Abstract][Full Text] [Related]
16. Antikinectin autoantibody in Behçet's disease and several other autoimmune connective tissue diseases.
Feng XG; Ye S; Lu Y; Xu XJ; Gu YY; Shen N; Ye P; Cheng FP; Wang AM; Chen SL
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S80-5. PubMed ID: 17949557
[TBL] [Abstract][Full Text] [Related]
17. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
18. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
19. Identification of kinectin as a novel Behçet's disease autoantigen.
Lu Y; Ye P; Chen SL; Tan EM; Chan EK
Arthritis Res Ther; 2005; 7(5):R1133-9. PubMed ID: 16207330
[TBL] [Abstract][Full Text] [Related]
20. Anti-alpha-enolase antibodies in Behçet's disease: a marker of mucocutaneous and articular disease activity?
Prado LL; Goncalves CR; Viana VT; Saad CGS; Bonfa E
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):28-32. PubMed ID: 29465373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
